Israel Crespo, MD
Gastroenterology · Tampa, FLNPI 1942302880
Payments from drug & device makers
Across 1,140 payments — averaging $337.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$237K
- Pfizer$88K
- AstraZeneca$18K
- AbbVie$15K
- Janssen Research & Development, LLC$12K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- plus $13K from 49 others
Across 6 payments — averaging $1061.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$6K
What the payments were for
- Consulting fees$140%
- Speaking & faculty fees$8,92529%
- Travel & lodging$580%
- Food & beverage$21,41070%
- Education$2621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$6,925
- STELARA$356
- OCALIVA$250
- Skyrizi$244
- X-Tack Endoscopic HeliX Tacking System$237
- ZENPEP$234
- Rinvoq$125
- Epclusa$125
- ORBERA Intragastric Balloon System$118
- CERTUS 140 MICROWAVE ABLATION SYSTEM$118
- REMICADE$115
- REZDIFFRA$114
- OMVOH$109
- Mavyret$105
- Reltone 200 Mg$102
- Reltone 400 Mg$102
How this compares
$384,750 in reported general payments places this provider in the 90th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 238 | $1,421,522 |
| ZenpepLipase/Protease/Amylase | 51 | $393,102 |
| StelaraUstekinumab | 12 | $336,434 |
| LinzessLinaclotide | 246 | $289,300 |
| Humira(Cf)Adalimumab | 15 | $206,779 |
| RinvoqUpadacitinib | 14 | $130,332 |
| XifaxanRifaximin | 43 | $100,177 |
| RelistorMethylnaltrexone Bromide | 17 | $38,110 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 277 | $18,460 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 96 | $16,162 |
| Ursodiol | 37 | $9,010 |
| Mesalamine ErMesalamine | 32 | $8,969 |
| DexilantDexlansoprazole | 11 | $8,920 |
| Colestipol Hcl | 72 | $8,714 |
| Pantoprazole Sodium | 656 | $7,848 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess, Humira(Cf), Rinvoq, Lumigan | $14,912 | $2,050,652524 claims |
| Aimmune Therapeutics, Inc.Zenpep | $323 | $393,10251 claims |
| Johnson & JohnsonStelara | $1,655 | $336,43412 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Relistor | $2,138 | $138,28660 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $63 | $16,16296 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $1,740 | $8,92011 claims |
| SandozLansoprazole | $14 | $1,13740 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Tampa
- Alan WeintraubTampa$4.7M
- Angel RosarioTampa$1.4M
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.